|
|
Volumn 163, Issue , 2003, Pages
|
|
Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study).
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
ENZYME INHIBITOR;
NITRILE;
TAMOXIFEN;
TRIAZOLE DERIVATIVE;
ADJUVANT CHEMOTHERAPY;
AGED;
BREAST TUMOR;
CLINICAL TRIAL;
FEMALE;
HUMAN;
MIDDLE AGED;
POSTMENOPAUSE;
PROGNOSIS;
REVIEW;
TUMOR RECURRENCE;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NITRILES;
POSTMENOPAUSE;
PROGNOSIS;
TAMOXIFEN;
TRIAZOLES;
|
|
EID: 0642375461
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-55647-0_9 Document Type: Review |
|
Times cited : (89)
|
|
References (10)
|
